13D Filing: Baker Bros. Advisors and Genomic Health Inc (GHDX)

Page 1 of 12

Genomic Health Inc (NASDAQ:GHDX): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D.

You can check out Baker Bros. Advisors’ latest holdings and filings here.

Please follow Baker Bros. Advisors (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Baker Bros. Advisors or update its stock holdings.

Follow Julian Baker And Felix Baker's Baker Bros. Advisors

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Baker Bros. Advisors 13,918,966 0 13,918,966 0 13,918,966 39.9%
Baker Bros. Advisors (GP) 13,918,966 0 13,918,966 0 13,918,966 39.9%
Julian C. Baker 14,092,863 0 14,092,863 0 14,092,863 40.4%
Felix J. Baker 14,092,863 0 14,092,863 0 14,092,863 40.4%
FBB Associates 173,897 0 173,897 0 173,897 0.5%

Follow Julian Baker And Felix Baker's Baker Bros. Advisors

Page 1 of 12 – SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

SCHEDULE 13D

Under the Securities Exchange Act of
1934

(Amendment No.
33)

Genomic Health,
Inc.

(Name of Issuer)

Common Stock,
par value $0.0001 per share

(Title of Class of Securities)

37244C101

(CUSIP number)

Alexandra A. Toohey

Chief Financial Officer

Baker Bros. Advisors LP

860 Washington Street, 3rd Floor

New York, NY 10014

(212) 339-5690

(Name, address and telephone number of person
authorized to receive notices and communications)

March 8, 2018

(Date of event which requires filing of
this statement)

If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule
13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. ¨

(Continued on the following pages)

Note: Schedules filed in paper format shall include a
signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to
be sent.

* The remainder of this cover page shall be filled out for
a reporting person’s initial filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).

Follow Genomic Health Inc (NASDAQ:GHDX)

Page 1 of 12